EC Number |
Application |
Reference |
---|
1.3.5.2 | drug development |
DHODH represents a potential target for anti-malarial therapy |
712475 |
1.3.5.2 | medicine |
- |
390926 |
1.3.5.2 | medicine |
background for the development of antipyrimidines with high efficacy for decreasing in situ pyrimidine nucleotide pools in Candida albicans |
673547 |
1.3.5.2 | medicine |
development of small molecule inhibitors against DHODH |
675294 |
1.3.5.2 | medicine |
DHODH represents a potential target for anti-malarial therapy |
712475 |
1.3.5.2 | medicine |
enzyme inhibition is a mechanism of action that may be relevant for the therapeutic effects of leflunomide |
390923 |
1.3.5.2 | medicine |
great interest in inhibitors as potential therapeutic agents for the treatment of diseases involving aberrant cell proliferation |
390922, 390923, 390924 |
1.3.5.2 | medicine |
inhibition of pyrimidine biosynthesis by targeting enzyme activity, mechanism for antimicrobial intervention |
390930 |
1.3.5.2 | medicine |
molecular target of the antiproliferative, immunosuppressive compound brequinar sodium |
390921 |
1.3.5.2 | medicine |
PfDHODH is a promising target for chemotherapeutic intervention in prevention of malaria |
675315 |